XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Collaboration Agreements, License Agreement and Revenues - Roll-forward of Related Contract Liabilities (Detail)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
AstraZeneca Agreements [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2023 $ (179,851)
Additions (24,950)
Currency Translation and Other 1,057
Recognized as Revenue 27,113
Balance at March 31, 2024 (176,631)
Drug Product Revenue, Net [Member] | Astellas Agreement [Member] | Europe [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2023 (16,925)
Reclassified to Accrued Liability 5,660
Recognized as Revenue 1,021
Balance at March 31, 2024 $ (10,244)